Browse treatments

…roviding both a predictive biomarker and a therapeutic axis for chemoimmunotherapy. Pharmacologic induction of ssDNA represents a rational strateg…

…op within macrophages.Conclusion The addition of bevacizumab to chemoimmunotherapy was associated with improved survival in ns‐NSCLC specifically …

… + B cells and hyperexpanded clonotypes were linked to improved chemoimmunotherapy response.Conclusions iCCA is characterised by a profoundly immu…

…d with chemotherapy has demonstrated higher response rates than chemotherapy alone in resectable esophageal squamous cell carcinoma (ESCC). …

…ts Twenty-seven patients with PD-L1-negative NSCLC treated with chemoimmunotherapy were included. At a median follow-up of 16.8 months (95% confid…

… appeared to correlate with a higher MPR and pCR rate following neoadjuvant therapy. This subset was enriched in treatment responders, exhibited tr…

… associate with poor prognosis, and contribute to resistance to chemoimmunotherapy. CLEVER-1 blockade using bexmarilimab reprogrammed TAMs toward …

…clinical efficacy in SCLC patients with previously treated with chemoimmunotherapy. However, the duration of treatment response is short, and the …

…Chemoimmunotherapy (CIT) has significantly improved outcomes in patients with exte…